The diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 study)

Diabetes Care

Volumn 34, Issue 3, 2011, Pages 233-239

  Charpentier, Guillaume ^a   Benhamou, Pierre Yves ^b   Dardari, Dured ^a   Clergeot, Annie ^c   Franc, Sylvia ^a   Schaepelynck Belicar, Pauline ^d   Catargi, Bogdan ^e   Melki, Vincent ^f   Chaillous, Lucy ^g   Farret, Anne ^h   Bosson, Jean Luc ^b   Penfornis, Alfred ^c  

^a CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f CHU RANGUEIL   (France)

^g CHU de Nantes   (France)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER PROGRAM; CONTROLLED STUDY; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; METABOLIC REGULATION; MULTICENTER STUDY; PATIENT MONITORING; PATIENT SATISFACTION; PERSONALIZED MEDICINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TELECONSULTATION; TELEMEDICINE; TREATMENT DURATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; SOFTWARE; TELEMEDICINE; YOUNG ADULT;

EID: 79956137229     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1259     Document Type: Article

References (17)

1. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose Adjustment For Normal Eating (DAFNE) randomised controlled trial. BMJ 2002;325:746
2. Bott S, Bott U, Berger M, Mühlhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 1997;40:926-932 (Pubitemid 27316573)
3. Fagot-Campagna A, Fosse S, Roudier C, et al. Characteristics, vascular risk and complications in people with diabetes, in metropolitan France: major improvements between ENTRED2001 and ENTRED2007 studies. Bulletin Epidemiologique Hebdomadaire 2009;42-43:450-455 [in French]
4. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
5. Franc S, Dardari D, Boucherie B, et al. Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients. Diabetes Metab 2009;35:463-468
6. Meadows K, Steen N, McColl E, et al. The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin requiring patients - development and psychometric evaluation. Qual Life Res 1996;5:242-254 (Pubitemid 26180672)
7. The DCCT Research Group. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988;11:725-732
8. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730-2732 (Pubitemid 44912209)
9. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-2569
10. Farmer A, Gibson OJ, Tarassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet Med 2005;22:1372-1378 (Pubitemid 41391314)
11. Verhoeven F, van Gemert-Pijnen L, Dijkstra K, Nijland N, Seydel E, Steehouder M. The contribution of teleconsultation and video-conferencing to diabetes care: a systematic literature review. J Med Internet Res 2007;9:e37
12. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab 2009;11:913-930
13. Montori VM, Helgemoe PK, Guyatt GH, et al. Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care 2004;27:1088-1094 (Pubitemid 38579771)
14. Thompson DM, Kozak SE, Sheps S. Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients: a randomized trial. CMAJ 1999;161:959-962 (Pubitemid 29495491)
15. Jansà M, Vidal M, Viaplana J, et al. Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control. Diabetes Res Clin Pract 2006;74:26-32 (Pubitemid 44810197)
16. Farmer AJ, Gibson OJ, Dudley C, et al. A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with type 1 diabetes (ISRCTN 46889446). Diabetes Care 2005;28:2697-2702 (Pubitemid 43951162)
17. Rossi MC, Nicolucci A, Di Bartolo P, et al. Diabetes Interactive Diary: a new telemedicine systemenabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study. Diabetes Care 2010;33:109-115